메뉴 건너뛰기




Volumn 14, Issue 1, 2014, Pages 22-31

Direct medical costs and medication compliance among fibromyalgia patients: Duloxetine initiators vs. Pregabalin initiators

Author keywords

Duloxetine; Fibromyalgia; Medical costs; Medication compliance; Pregabalin

Indexed keywords

ANTICONVULSIVE AGENT; ANTIDEPRESSANT AGENT; ANXIOLYTIC AGENT; DOPAMINE RECEPTOR STIMULATING AGENT; DULOXETINE; MUSCLE RELAXANT AGENT; NONSTEROID ANTIINFLAMMATORY AGENT; OPIATE; PREGABALIN; SEROTONIN 3 ANTAGONIST; SEROTONIN NORADRENALIN REUPTAKE INHIBITOR; SEROTONIN UPTAKE INHIBITOR; TOPICAL AGENT; TRICYCLIC ANTIDEPRESSANT AGENT;

EID: 84891632294     PISSN: 15307085     EISSN: 15332500     Source Type: Journal    
DOI: 10.1111/papr.12044     Document Type: Article
Times cited : (12)

References (56)
  • 1
    • 0023191317 scopus 로고
    • Fibromyalgia
    • Bennett RM. Fibromyalgia. JAMA. 1987;257:2802-2803.
    • (1987) JAMA , vol.257 , pp. 2802-2803
    • Bennett, R.M.1
  • 3
    • 84856599951 scopus 로고    scopus 로고
    • Fibromyalgia: mechanisms and potential impact of the ACR 2010 classification criteria
    • McBeth J, Mulvey MR. Fibromyalgia: mechanisms and potential impact of the ACR 2010 classification criteria. Nat Rev Rheumatol. 2012;8:108-116.
    • (2012) Nat Rev Rheumatol , vol.8 , pp. 108-116
    • McBeth, J.1    Mulvey, M.R.2
  • 4
    • 80053129151 scopus 로고    scopus 로고
    • Fibromyalgia diagnosis and diagnostic criteria
    • Wolfe F, Hauser W. Fibromyalgia diagnosis and diagnostic criteria. Ann Med. 2011;43:495-502.
    • (2011) Ann Med , vol.43 , pp. 495-502
    • Wolfe, F.1    Hauser, W.2
  • 5
    • 80051771019 scopus 로고    scopus 로고
    • Medication dosing patterns associated with duloxetine and pregabalin among patients with fibromyalgia
    • Sun P, Zhao Y, Zhao Z, Watson P. Medication dosing patterns associated with duloxetine and pregabalin among patients with fibromyalgia. Curr Med Res Opin. 2011;27:1793-801.
    • (2011) Curr Med Res Opin , vol.27 , pp. 1793-1801
    • Sun, P.1    Zhao, Y.2    Zhao, Z.3    Watson, P.4
  • 6
    • 79955588326 scopus 로고    scopus 로고
    • Comparison of medication adherence and healthcare costs between duloxetine and pregabalin initiators among patients with fibromyalgia
    • Zhao Y, Sun P, Watson P, Mitchell B, Swindle R. Comparison of medication adherence and healthcare costs between duloxetine and pregabalin initiators among patients with fibromyalgia. Pain Pract. 2011;11:204-216.
    • (2011) Pain Pract , vol.11 , pp. 204-216
    • Zhao, Y.1    Sun, P.2    Watson, P.3    Mitchell, B.4    Swindle, R.5
  • 7
    • 77953120247 scopus 로고    scopus 로고
    • Prevalence of fibromyalgia: a survey in five European countries
    • Branco JC, Bannwarth B, Failde I, et al. Prevalence of fibromyalgia: a survey in five European countries. Semin Arthritis Rheum. 2009; 39: 448-453.
    • (2009) Semin Arthritis Rheum , vol.39 , pp. 448-453
    • Branco, J.C.1    Bannwarth, B.2    Failde, I.3
  • 9
    • 52649170911 scopus 로고    scopus 로고
    • Prevalence and impact of fibromyalgia on function and quality of life in individuals from the general population: results from a nationwide study in Spain
    • Mas AJ, Carmona L, Valverde M, Ribas B. Prevalence and impact of fibromyalgia on function and quality of life in individuals from the general population: results from a nationwide study in Spain. Clin Exp Rheumatol. 2008;26:519-526.
    • (2008) Clin Exp Rheumatol , vol.26 , pp. 519-526
    • Mas, A.J.1    Carmona, L.2    Valverde, M.3    Ribas, B.4
  • 10
    • 34247494827 scopus 로고    scopus 로고
    • The prevalence of fibromyalgia in Japanese workers
    • Toda K. The prevalence of fibromyalgia in Japanese workers. Scand J Rheumatol. 2007;36:140-144.
    • (2007) Scand J Rheumatol , vol.36 , pp. 140-144
    • Toda, K.1
  • 11
    • 0041570006 scopus 로고    scopus 로고
    • Elements of fibromyalgia in an open population
    • Schochat T, Raspe H. Elements of fibromyalgia in an open population. Rheumatology (Oxford). 2003;42:829-835.
    • (2003) Rheumatology (Oxford) , vol.42 , pp. 829-835
    • Schochat, T.1    Raspe, H.2
  • 13
    • 0029763121 scopus 로고    scopus 로고
    • The prevalence and meaning of fatigue in rheumatic disease
    • Wolfe F, Hawley DJ, Wilson K. The prevalence and meaning of fatigue in rheumatic disease. J Rheumatol. 1996;23:1407-1417.
    • (1996) J Rheumatol , vol.23 , pp. 1407-1417
    • Wolfe, F.1    Hawley, D.J.2    Wilson, K.3
  • 15
    • 0028890678 scopus 로고
    • The prevalence and characteristics of fibromyalgia in the general population
    • Wolfe F, Ross K, Anderson J, Russell IJ, Hebert L. The prevalence and characteristics of fibromyalgia in the general population. Arthritis Rheum. 1995;38:19-28.
    • (1995) Arthritis Rheum , vol.38 , pp. 19-28
    • Wolfe, F.1    Ross, K.2    Anderson, J.3    Russell, I.J.4    Hebert, L.5
  • 17
    • 85030492604 scopus 로고    scopus 로고
    • NFA. Prevalence of Fibromyalgia. (accessed May 5, 2009).
    • NFA. Prevalence of Fibromyalgia. 2009. http://www.fmaware.org/site/PageServer?pagename=fibromyalgia_affected (accessed May 5, 2009).
    • (2009)
  • 18
    • 85030495707 scopus 로고    scopus 로고
    • WD. Prevalence and Incidence of Fibromyalgia. (accessed May 5, 2009).
    • WD. Prevalence and Incidence of Fibromyalgia. 2009. http://www.wrongdiagnosis.com/f/fibromyalgia/stats.htm (accessed May 5, 2009).
    • (2009)
  • 19
    • 84891623709 scopus 로고    scopus 로고
    • NIAMS. Fibromyalgia. (accessed May 5, 2009).
    • NIAMS. Fibromyalgia. 1999. http://www.niams.nih.gov/Health_Info/Fibromyalgia/default.asp (accessed May 5, 2009).
    • (1999)
  • 20
    • 41849093775 scopus 로고    scopus 로고
    • EULAR evidence-based recommendations for the management of fibromyalgia syndrome
    • Carville SF, Arendt-Nielsen S, Bliddal H, et al. EULAR evidence-based recommendations for the management of fibromyalgia syndrome. Ann Rheum Dis. 2008;67:536-541.
    • (2008) Ann Rheum Dis , vol.67 , pp. 536-541
    • Carville, S.F.1    Arendt-Nielsen, S.2    Bliddal, H.3
  • 22
    • 64249124632 scopus 로고    scopus 로고
    • Fibromyalgia: presentation and management with a focus on pharmacological treatment
    • Sumpton JE, Moulin DE. Fibromyalgia: presentation and management with a focus on pharmacological treatment. Pain Res Manag. 2008;13:477-483.
    • (2008) Pain Res Manag , vol.13 , pp. 477-483
    • Sumpton, J.E.1    Moulin, D.E.2
  • 23
    • 33745588681 scopus 로고    scopus 로고
    • Guideline for the management of fibromyalgia syndrome pain in adults and children
    • Glenview, IL: American Pain Society (APS); 2005. 109 p. Clinical practice guideline; no. 4.
    • Buckhardt CS, Goldenberg D, Crofford L, et al. Guideline for the management of fibromyalgia syndrome pain in adults and children. Glenview, IL: American Pain Society (APS); 2005. 109 p. Clinical practice guideline; no. 4.
    • Buckhardt, C.S.1    Goldenberg, D.2    Crofford, L.3
  • 24
    • 72049123263 scopus 로고    scopus 로고
    • Guidelines on the management of fibromyalgia syndrome-a systematic review
    • Hauser W, Thieme K, Turk DC. Guidelines on the management of fibromyalgia syndrome-a systematic review. Eur J Pain. 2009;14:5-10.
    • (2009) Eur J Pain , vol.14 , pp. 5-10
    • Hauser, W.1    Thieme, K.2    Turk, D.C.3
  • 25
    • 0036196878 scopus 로고    scopus 로고
    • Management of fibromyalgia: what are the best treatment choices?
    • Forseth KK, Gran JT. Management of fibromyalgia: what are the best treatment choices? Drugs. 2002;62:577-592.
    • (2002) Drugs. , vol.62 , pp. 577-592
    • Forseth, K.K.1    Gran, J.T.2
  • 26
    • 46249108179 scopus 로고    scopus 로고
    • Ottawa Panel evidence-based clinical practice guidelines for aerobic fitness exercises in the management of fibromyalgia: part 1
    • Brosseau L, Wells GA, Tugwell P, et al. Ottawa Panel evidence-based clinical practice guidelines for aerobic fitness exercises in the management of fibromyalgia: part 1. Phys Ther. 2008;88:857-871.
    • (2008) Phys Ther , vol.88 , pp. 857-871
    • Brosseau, L.1    Wells, G.A.2    Tugwell, P.3
  • 27
    • 46249100866 scopus 로고    scopus 로고
    • Ottawa panel evidence-based clinical practice guidelines for strengthening exercises in the management of fibromyalgia: part 2
    • Brosseau L, Wells GA, Tugwell P, et al. Ottawa panel evidence-based clinical practice guidelines for strengthening exercises in the management of fibromyalgia: part 2. Phys Ther. 2008;88:873-886.
    • (2008) Phys Ther , vol.88 , pp. 873-886
    • Brosseau, L.1    Wells, G.A.2    Tugwell, P.3
  • 28
    • 41649090384 scopus 로고    scopus 로고
    • Pain management in fibromyalgia
    • Crofford LJ. Pain management in fibromyalgia. Curr Opin Rheumatol. 2008;20:246-250.
    • (2008) Curr Opin Rheumatol , vol.20 , pp. 246-250
    • Crofford, L.J.1
  • 29
    • 67449142554 scopus 로고    scopus 로고
    • Effectiveness of the psychological and pharmacological treatment of catastrophization in patients with fibromyalgia: a randomized controlled trial
    • Garcia-Campayo J, Serrano-Blanco A, Rodero B, et al. Effectiveness of the psychological and pharmacological treatment of catastrophization in patients with fibromyalgia: a randomized controlled trial. Trials. 2009;10:24.
    • (2009) Trials , vol.10 , pp. 24
    • Garcia-Campayo, J.1    Serrano-Blanco, A.2    Rodero, B.3
  • 30
    • 43549091316 scopus 로고    scopus 로고
    • Efficacy and safety of duloxetine for treatment of fibromyalgia in patients with or without major depressive disorder: results from a 6-month, randomized, double-blind, placebo-controlled, fixed-dose trial
    • Russell IJ, Mease PJ, Smith TR, et al. Efficacy and safety of duloxetine for treatment of fibromyalgia in patients with or without major depressive disorder: results from a 6-month, randomized, double-blind, placebo-controlled, fixed-dose trial. Pain. 2008;136:432-444.
    • (2008) Pain , vol.136 , pp. 432-444
    • Russell, I.J.1    Mease, P.J.2    Smith, T.R.3
  • 31
    • 40649095921 scopus 로고    scopus 로고
    • A randomized, double-blind, placebo-controlled, phase III trial of pregabalin in the treatment of patients with fibromyalgia
    • Mease PJ, Russell IJ, Arnold LM, et al. A randomized, double-blind, placebo-controlled, phase III trial of pregabalin in the treatment of patients with fibromyalgia. J Rheumatol. 2008;35:502-514.
    • (2008) J Rheumatol , vol.35 , pp. 502-514
    • Mease, P.J.1    Russell, I.J.2    Arnold, L.M.3
  • 32
    • 43549104210 scopus 로고    scopus 로고
    • Fibromyalgia relapse evaluation and efficacy for durability of meaningful relief (FREEDOM): a 6-month, double-blind, placebo-controlled trial with pregabalin
    • Crofford LJ, Mease PJ, Simpson SL, et al. Fibromyalgia relapse evaluation and efficacy for durability of meaningful relief (FREEDOM): a 6-month, double-blind, placebo-controlled trial with pregabalin. Pain. 2008;136:419-431.
    • (2008) Pain , vol.136 , pp. 419-431
    • Crofford, L.J.1    Mease, P.J.2    Simpson, S.L.3
  • 33
    • 57649234533 scopus 로고    scopus 로고
    • Milnacipran for the treatment of fibromyalgia in adults: a 15-week, multicenter, randomized, double-blind, placebo-controlled, multiple-dose clinical trial
    • erratum appears in Clin Ther. 2009 Feb;31(2):446].
    • Clauw DJ, Mease P, Palmer RH, Gendreau RM, Wang Y. Milnacipran for the treatment of fibromyalgia in adults: a 15-week, multicenter, randomized, double-blind, placebo-controlled, multiple-dose clinical trial. [erratum appears in Clin Ther. 2009 Feb;31(2):446]. Clin Ther. 2008;30:1988-2004.
    • (2008) Clin Ther , vol.30 , pp. 1988-2004
    • Clauw, D.J.1    Mease, P.2    Palmer, R.H.3    Gendreau, R.M.4    Wang, Y.5
  • 35
    • 26444518188 scopus 로고    scopus 로고
    • Efficacy of milnacipran in patients with fibromyalgia
    • Gendreau RM, Thorn MD, Gendreau JF, et al. Efficacy of milnacipran in patients with fibromyalgia. J Rheumatol. 2005;32:1975-1985.
    • (2005) J Rheumatol. , vol.32 , pp. 1975-1985
    • Gendreau, R.M.1    Thorn, M.D.2    Gendreau, J.F.3
  • 36
    • 20244389715 scopus 로고    scopus 로고
    • Pregabalin for the treatment of fibromyalgia syndrome: results of a randomized, double-blind, placebo-controlled trial
    • Crofford LJ, Rowbotham MC, Mease PJ, et al. Pregabalin for the treatment of fibromyalgia syndrome: results of a randomized, double-blind, placebo-controlled trial. Arthritis Rheum. 2005;52:1264-1273.
    • (2005) Arthritis Rheum , vol.52 , pp. 1264-1273
    • Crofford, L.J.1    Rowbotham, M.C.2    Mease, P.J.3
  • 37
    • 28644442626 scopus 로고    scopus 로고
    • A randomized, double-blind, placebo-controlled trial of duloxetine in the treatment of women with fibromyalgia with or without major depressive disorder
    • Arnold LM, Rosen A, Pritchett YL, et al. A randomized, double-blind, placebo-controlled trial of duloxetine in the treatment of women with fibromyalgia with or without major depressive disorder. Pain. 2005;119:5-15.
    • (2005) Pain. , vol.119 , pp. 5-15
    • Arnold, L.M.1    Rosen, A.2    Pritchett, Y.L.3
  • 38
    • 6344231258 scopus 로고    scopus 로고
    • A double-blind placebo-controlled trial of milnacipran in the treatment of fibromyalgia
    • Vitton O, Gendreau M, Gendreau J, Kranzler J, Rao SG. A double-blind placebo-controlled trial of milnacipran in the treatment of fibromyalgia. Hum Psychopharmacol. 2004;19(Suppl 1):S27-35.
    • (2004) Hum Psychopharmacol , vol.19 , Issue.SUPPL. 1
    • Vitton, O.1    Gendreau, M.2    Gendreau, J.3    Kranzler, J.4    Rao, S.G.5
  • 39
    • 4444381930 scopus 로고    scopus 로고
    • A double-blind, multicenter trial comparing duloxetine with placebo in the treatment of fibromyalgia patients with or without major depressive disorder
    • Arnold LM, Lu Y, Crofford LJ, et al. A double-blind, multicenter trial comparing duloxetine with placebo in the treatment of fibromyalgia patients with or without major depressive disorder. Arthritis Rheum. 2004;50:2974-2984.
    • (2004) Arthritis Rheum , vol.50 , pp. 2974-2984
    • Arnold, L.M.1    Lu, Y.2    Crofford, L.J.3
  • 40
    • 77951765546 scopus 로고    scopus 로고
    • Pregabalin in fibromyalgia: meta-analysis of efficacy and safety from company clinical trial reports
    • Straube S, Derry S, Moore RA, McQuay HJ. Pregabalin in fibromyalgia: meta-analysis of efficacy and safety from company clinical trial reports. Rheumatology (Oxford). 2010;49:706-715.
    • (2010) Rheumatology (Oxford) , vol.49 , pp. 706-715
    • Straube, S.1    Derry, S.2    Moore, R.A.3    McQuay, H.J.4
  • 41
    • 77952742362 scopus 로고    scopus 로고
    • Comparative efficacy and harms of duloxetine, milnacipran, and pregabalin in fibromyalgia syndrome
    • Hauser W, Petzke F, Sommer C. Comparative efficacy and harms of duloxetine, milnacipran, and pregabalin in fibromyalgia syndrome. J Pain. 2010;11:505-521.
    • (2010) J Pain. , vol.11 , pp. 505-521
    • Hauser, W.1    Petzke, F.2    Sommer, C.3
  • 42
    • 84856058020 scopus 로고    scopus 로고
    • Clinical comorbidities, treatment patterns, and healthcare costs among patients with fibromyalgia newly prescribed pregabalin or duloxetine in usual care
    • Gore M, Tai KS, Chandran A, Zlateva G, Leslie D. Clinical comorbidities, treatment patterns, and healthcare costs among patients with fibromyalgia newly prescribed pregabalin or duloxetine in usual care. J Med Econ. 2012;15:19-31.
    • (2012) J Med Econ. , vol.15 , pp. 19-31
    • Gore, M.1    Tai, K.S.2    Chandran, A.3    Zlateva, G.4    Leslie, D.5
  • 44
    • 80655127867 scopus 로고    scopus 로고
    • Health outcomes and costs among employees with fibromyalgia treated with pregabalin vs. standard of care
    • Kleinman NL, Sanchez RJ, Lynch WD, Cappelleri JC, Beren IA, Joshi AV. Health outcomes and costs among employees with fibromyalgia treated with pregabalin vs. standard of care. Pain Pract. 2011;11:540-551.
    • (2011) Pain Pract. , vol.11 , pp. 540-551
    • Kleinman, N.L.1    Sanchez, R.J.2    Lynch, W.D.3    Cappelleri, J.C.4    Beren, I.A.5    Joshi, A.V.6
  • 45
    • 79955591100 scopus 로고    scopus 로고
    • Real-world evaluation of health-care resource utilization and costs in employees with fibromyalgia treated with pregabalin or duloxetine
    • Harnett J, Margolis J, Cao Z, et al. Real-world evaluation of health-care resource utilization and costs in employees with fibromyalgia treated with pregabalin or duloxetine. Pain Pract. 2011;11:217-229.
    • (2011) Pain Pract. , vol.11 , pp. 217-229
    • Harnett, J.1    Margolis, J.2    Cao, Z.3
  • 46
    • 0026576098 scopus 로고
    • Comorbidity of fibromyalgia with medical and psychiatric disorders
    • Hudson JI, Goldenberg DL, Pope HG, et al. Comorbidity of fibromyalgia with medical and psychiatric disorders. Am J Med. 1992;92:363-367.
    • (1992) Am J Med , vol.92 , pp. 363-367
    • Hudson, J.I.1    Goldenberg, D.L.2    Pope, H.G.3
  • 47
    • 1642485110 scopus 로고    scopus 로고
    • Comorbidity of fibromyalgia and posttraumatic stress disorder symptoms in a community sample of women
    • Raphael KG, Janal MN, Nayak S. Comorbidity of fibromyalgia and posttraumatic stress disorder symptoms in a community sample of women. Pain Med. 2004;5:33-41.
    • (2004) Pain Med. , vol.5 , pp. 33-41
    • Raphael, K.G.1    Janal, M.N.2    Nayak, S.3
  • 48
    • 17044380264 scopus 로고    scopus 로고
    • Psychiatric comorbidity in fibromyalgia
    • Bradley LA. Psychiatric comorbidity in fibromyalgia. Curr Pain Headache Rep. 2005;9:79-86.
    • (2005) Curr Pain Headache Rep , vol.9 , pp. 79-86
    • Bradley, L.A.1
  • 49
    • 33645749180 scopus 로고    scopus 로고
    • Is there an association between fibromyalgia and an increase in comorbidity: neoplastic and cardiovascular diseases, infections and mortality?
    • Chamizo-Carmona E. Is there an association between fibromyalgia and an increase in comorbidity: neoplastic and cardiovascular diseases, infections and mortality?. Reumatol Clin. 2005;1:200-210.
    • (2005) Reumatol Clin. , vol.1 , pp. 200-210
    • Chamizo-Carmona, E.1
  • 50
    • 34848818749 scopus 로고    scopus 로고
    • Comorbidity of fibromyalgia and psychiatric disorders
    • Buskila D, Cohen H. Comorbidity of fibromyalgia and psychiatric disorders. Curr Pain Headache Rep. 2007;11:333-338.
    • (2007) Curr Pain Headache Rep , vol.11 , pp. 333-338
    • Buskila, D.1    Cohen, H.2
  • 53
    • 61849106634 scopus 로고    scopus 로고
    • Fibromyalgia comorbidity in primary headaches
    • de Tommaso M, Sardaro M, Serpino C, et al. Fibromyalgia comorbidity in primary headaches. Cephalalgia. 2009;29:453-464.
    • (2009) Cephalalgia , vol.29 , pp. 453-464
    • de Tommaso, M.1    Sardaro, M.2    Serpino, C.3
  • 54
    • 79951820154 scopus 로고    scopus 로고
    • Fibromyalgia and psychiatric comorbidity: their effect on the quality of life patients
    • Gonzalez E, Elorza J, Failde I. Fibromyalgia and psychiatric comorbidity: their effect on the quality of life patients. Actas Esp Psiquiatr. 2010;38:295-300.
    • (2010) Actas Esp Psiquiatr. , vol.38 , pp. 295-300
    • Gonzalez, E.1    Elorza, J.2    Failde, I.3
  • 55
    • 80052508348 scopus 로고    scopus 로고
    • Fibromyalgia symptoms, physical function, and comorbidity in middle-aged and older adults
    • Shillam CR, Dupree Jones K, Miller L. Fibromyalgia symptoms, physical function, and comorbidity in middle-aged and older adults. Nurs Res. 2011;60:309-317.
    • (2011) Nurs Res , vol.60 , pp. 309-317
    • Shillam, C.R.1    Dupree Jones, K.2    Miller, L.3
  • 56
    • 77951622706 scopus 로고
    • The central role of the propensity score in observational studies for causal effects
    • Rosenbaum P, Rubin D. The central role of the propensity score in observational studies for causal effects. Biometrika. 1983;70:41-55.
    • (1983) Biometrika , vol.70 , pp. 41-55
    • Rosenbaum, P.1    Rubin, D.2


* 이 정보는 Elsevier사의 SCOPUS DB에서 KISTI가 분석하여 추출한 것입니다.